BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis-March 2024-www.financetom.com

BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Johnson & Johnson To Obtain Rights To A Clinical-Stage Bispecific Antibody To Address Distinct Patient Needs In Atopic Dermatitis

May 28, 2024 5:05 AM

May 28 (Reuters) - Johnson & Johnson:

* JOHNSON & JOHNSON TO OBTAIN RIGHTS TO A CLINICAL-STAGE

BISPECIFIC ANTIBODY TO ADDRESS DISTINCT PATIENT NEEDS IN ATOPIC

DERMATITIS

* J&J - PROPOSED DEAL FOR ALL-CASH TRANSACTION OF

APPROXIMATELY

$1.25 BILLION

* J&J - PROPOSED DEAL FOR ALL-CASH TRANSACTION OF

APPROXIMATELY

$1.25 BILLION

* J&J: ENTERS AGREEMENT WITH NUMAB THERAPEUTICS TO ACQUIRE

ITS

WHOLLY OWNED SUBSIDIARY FOR GLOBAL RIGHTS TO NM26

Source text for Eikon:

Further company coverage:

Previous page： Ensign Group Insider Sold Shares Worth $1,437,438, According to a Recent SEC Filing Next page： For global investors, China is a slow-burning trade

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Ensign Group Insider Sold Shares Worth $1,437,438, According to a Recent SEC Filing

Jul 16, 2024

03:27 AM EDT, 07/16/2024 (MT Newswires) -- Spencer Burton, President and Chief Operating Officer, on July 11, 2024, sold 10,618 shares in Ensign Group ( ENSG ) for $1,437,438. Following the Form 4 filing with the SEC, Burton has control over a total of 42,629 shares of the company, with 42,629 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1125376/000112537624000128/xslF345X03/wk-form4_1721086634.xml Price: 135.22, Change:...

For global investors, China is a slow-burning trade

Jul 16, 2024

NEW YORK/SINGAPORE (Reuters) -For global investors with money in China's stock markets, the latest economic numbers are not of any comfort and just a reminder that the recovery they are betting on will take a while to happen. Monday's second-quarter growth figures in China pointed not only to an economy growing below target, but also showed there is no sign...

H B Fuller Insider Sold Shares Worth $1,958,763, According to a Recent SEC Filing

Jul 16, 2024

03:29 AM EDT, 07/16/2024 (MT Newswires) -- Heather Campe, Senior Vice President, International Growth, on July 12, 2024, sold 23,696 shares in H B Fuller ( FUL ) for $1,958,763. Following the Form 4 filing with the SEC, Campe has control over a total of 19,742 shares of the company, with 19,742 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/39368/000122520824007434/xslF345X03/doc4.xml Price: 81.76,...

Masimo initiates legal action against activist investor Politan

Jul 16, 2024

July 16 (Reuters) - Medical device maker Masimo Corp ( MASI ) on Tuesday said it has started litigation against Politan Capital in a California federal court, seeking to force the activist investor to correct material misstatements and omissions in its proxy materials. Masimo ( MASI ) is locked in a proxy contest with Politan, which has long criticized the...